Thumbnail Image
Publication

Efficacy of lenvatinib in patients with advanced pancreatic (panNETs) and gastrointestinal (giNETs) grade 1/2 (G1/G2) neuroendocrine tumors: results of the international phase II TALENT trial (GETNE 1509)

Capdevila, J
; 
Fazio, N
; 
Lopez, C
; 
Teule, A
; 
Valle, Juan W
; 
Tafuto, S
; 
Custodio, A
; 
Reed, N
; 
Raderer, M
; 
Grande, E
... show 10 more
Citations
Altmetric:
Abstract
Authors
Capdevila, J
Fazio, N
Lopez, C
Teule, A
Valle, Juan W
Tafuto, S
Custodio, A
Reed, N
Raderer, M
Grande, E
Garcia-Carbonero, R
Fonseca, P
Alonso, V
Antonuzzo, L
Spallanzani, A
Berruti, A
Garcia, I
La, Casta A
Hernando, J
Ibrahim, T
Affiliation
Gastrointestinal and Endocrine Tumor Unit, Vall d'Hebron University Hospital, Vall Hebron Institute of Oncology (VHIO) Barcelona, Spain
Description
Date
2018
Publisher
Collections
All Christie Publications
Show all metadata
Files
Thumbnail Image
From UNPAYWALL
Adobe PDF, 112.44 KB
Keywords
Type
Meetings and Proceedings
Citation
Capdevila J, Fazio N, Lopez C, Teule A, Valle JW, Tafuto S, et al. 1307OEfficacy of lenvatinib in patients with advanced pancreatic (panNETs) and gastrointestinal (giNETs) grade 1/2 (G1/G2) neuroendocrine tumors: results of the international phase II TALENT trial (GETNE 1509). Ann Oncol. 2018;29(suppl_8):467.
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/621809
Embedded videos